Adverse Events of Ruxolitinib in Vitiligo Trials

Heather Woolery-Lloyd, MD, discusses the adverse event profile of topical ruxolitinib for treatment of vitiligo, highlighting the well-tolerated nature of the drug.

Related Keywords

Nada Elbuluk ,Heather Woolery Lloyd ,Seemal Desai , ,Vitiligo ,Autoimmune Disease ,Ruxolitinib ,Application Site Acne ,Adverse Events Of Ruxolitinib ,